A retrospective, multicenter real-life study comparing original and biosimilar infliximab (CTP-13) in biologic-naive patients with Crohn's disease and ulcerative colitis
Latest Information Update: 23 Jul 2021
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 23 Jul 2021 New trial record